首页> 外国专利> NON-INFECTIOUS FOR HUMAN ADENOVIRUS AS VECTOR FOR SUBSTITUTION GENETIC THERAPY OF ANGIOGENESIS DISORDER PROVIDING EFFECTIVE SYNTHESIS OF HUMAN ANGIOGENIN IN MAMMALIAN TRANSFECTED CELLS, METHOD FOR ANGIOGENESIS INDUCTION, METHOD FOR TREATMENT OF ISCHEMIC DISEASE, COMPOSITION FOR INDUCTION OF ANGIOGENESIS AND TREATMENT OF ISCHEMIC DISEASE

NON-INFECTIOUS FOR HUMAN ADENOVIRUS AS VECTOR FOR SUBSTITUTION GENETIC THERAPY OF ANGIOGENESIS DISORDER PROVIDING EFFECTIVE SYNTHESIS OF HUMAN ANGIOGENIN IN MAMMALIAN TRANSFECTED CELLS, METHOD FOR ANGIOGENESIS INDUCTION, METHOD FOR TREATMENT OF ISCHEMIC DISEASE, COMPOSITION FOR INDUCTION OF ANGIOGENESIS AND TREATMENT OF ISCHEMIC DISEASE

机译:对人类腺病毒的非感染性,作为血管生成的替代遗传治疗的媒介,可以在哺乳动物转化的细胞中有效合成人类血管生成素,用于血管生成的诱导,治疗,缺血性肿瘤的治疗和缺血性疾病的治疗

摘要

FIELD: medicine, biotechnology, genetic engineering.;SUBSTANCE: invention proposes non-infectious for human adenovirus as a vector for substitution genetic therapy of angiogenesis disorders. This adenovirus is replicative-defect in mammalian cells (including humans) in region that is not essential for replication in avian cells and carries expression cassette consisting of cytomegalovirus promoter, human angiogenin gene cDNA and polyadenylation signal of bovine hormone growth, and provides induction of angiogenesis. Invention proposes a method for induction of angiogenesis and method for treatment of ischemic disease by using a composition comprising the proposed recombinant adenovirus. Invention can be used in medicine in treatment of cardiovascular diseases.;EFFECT: valuable medicinal properties of adenovirus and composition.;5 cl, 1 dwg, 4 ex
机译:领域:发明提出了对人腺病毒非感染性作为用于替代血管生成疾病的基因治疗的载体。这种腺病毒在哺乳动物细胞(包括人类)中的复制缺陷中,对于在禽类细胞中复制不是必需的,并且携带由巨细胞病毒启动子,人血管生成素基因cDNA和牛激素生长的聚腺苷酸化信号组成的表达盒,并诱导血管生成。本发明提出了一种通过使用包含所提出的重组腺病毒的组合物来诱导血管生成的方法和用于治疗缺血性疾病的方法。发明可用于治疗心血管疾病的药物。效果:腺病毒的有价值的医学特性和组成; 5 cl,1 dwg,4 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号